SF Healthcare Week: A buy side perspective of biotech with Affinity's Patrick Nosker
- blonca9
- Jan 8, 2024
- 1 min read
Patrick Nosker gives his take on today's conference news and highlights the science behind some of his firm's top holdings like Apogee, Teva, CymaBay, and Madrigal.
